|
Shares of Tiffany & Co. (NYSE: TIF) climbed about 4% by afternoon trade on Tuesday after the luxury jewelry maker reported better-than-expected fiscal first quarter results, led by strong growth in international markets. For the fiscal first quarter ended April 30, the Company reported adjusted earnings of $89 million or 70 cents a share. Sales [...]
Canadian drug- maker, Valeant Pharmaceuticals International Inc. (NYSE: VRX) announced on Monday that it has agreed to buy Bausch & Lomb from Warbug Pincus in an all-cash deal estimated at $8.7 billion, a move which is expected to help the company to gain traction in global ophthalmic pharmaceutical market.
[...]
Generic drug maker Actavis Inc (NYSE: ACT) announced on Monday that it has agreed to acquire specialty pharmaceutical Company, Warner Chilcott Plc (NASDAQ: WCRX) in stock swap deal, valued at almost $5 billion.
[...]
Shares of Conceptus Inc. (NASDAQ: CPTS) rallied about 19.40% by afternoon trade after Bayer AG said that it has agreed to acquire Conceptus in deal estimated at euro 852 million ( $1.1 billion ) as the health-care company looks to gain traction in women contraceptive market. Bayer said that in next 10 days period, it [...]
Shares of Valeant Pharmaceuticals International (NYSE: VRX), a specialty pharmaceutical company engaged in the development, manufacturing and marketing of a range of pharmaceutical products, are soaring in early trading today.
[...]
Valeant Pharmaceuticals International (NYSE: VRX) Director Laurence E. Paul, this week, bought $276,000 worth of VRX shares.
[...]
|
Recent Posts
- Who is Richard Dennis and the Turtles?
- Mosex Mark, Kodak Insider, buys $563,500 worth of shares
- CEO Christopher Pappas,Luby’s Inc Insider Buys $180,000 of Shares on Jan 27, 2015 and Jan 29, 2015.
- CEO Jean-Francois Huc, BioAmber Insider Buys $48,000 of Shares
- CEO Richard Willis,Speed Commerce Insider Buys $7,500 of Shares
|
Recent Comments